OBJECTIVE To assess whether the use of inverted lead aVR ( −aVR ) would improve the classification of acute inferior or lateral myocardial infarction presenting with ST elevation. DESIGN Observational ...

Figure 1. ST elevation in anteroseptal and lateral leads (V2-V6, Lead 1, and aVL) with reciprocal ST depression in the inferior leads (lead 3 and aVF). On arrival, he had sinus tachycardia at 105 ...

Methylergometrine maleate testing (0.15 mg IV) caused akinesia of the midcavity inferior and inferoseptal walls (Movie II in the online-only Data Supplement) associated with transient 2-mm ST ...

The history, ECG, age, risk factors, and troponin (HEART) score was developed as a rapid risk stratification tool. It has ...

Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care ...

This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

Charles Antzelevitch, Ph.D. Disclosures Pacing Clin Electrophysiol. 2006;29 (10):1130-1159.

HeartSciences' first product candidate for FDA clearance, the MyoVista® wavECG™, or the MyoVista®, is a resting 12-lead ECG that is also designed to provide diagnostic information related to ...

(RTTNews) - HeartSciences (HSCS, HSCSW) announced that the FDA has granted Breakthrough Device designation for its Aortic Stenosis ECG algorithm. The algorithm would offer a AI-driven ECG solution ...

HeartSciences (HSCS) announced that the U.S. Food and Drug Administration has granted Breakthrough Device designationless than BDD, for its Aortic Stenosis ECG algorithm. The algorithm would offer ...

Electrocardiogram (ECG) steganography represents an emerging fusion of biomedical signal processing and cryptographic techniques aimed at safeguarding patients’ sensitive medical data. By ...